Log In
Print
BCIQ
Print
Print this Print this
 

Zevalin, ibritumomab tiuxetan

Also known as: IDEC-Y2B8

  Manage Alerts
Collapse Summary General Information
Company Spectrum Pharmaceuticals Inc.
DescriptionYttrium-90-radiolabeled murine mAb against CD20 on B cells
Molecular Target CD20
Mechanism of ActionRadiolabelled antibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today